Ignite Creation Date:
2024-05-06 @ 6:52 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05814718
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-04-18
First Post:
2023-02-22
Brief Title:
Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT
Sponsor:
First Affiliated Hospital Xian Jiaotong University
Organization:
First Affiliated Hospital Xian Jiaotong University
Study Overview
Official Title:
Multicenter Randomized Controlled Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Carmustine Etoposide and Cytarabine Modified BEAM Protocol for T Cell Lymphoma Underwent Autologous Stem Cell Transplantation
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A multicenter randomized study on the efficacy and safety of mitoxantrone hydrochloride liposome injection combined with carmustine etoposide and cytarabine modified BEAM protocol in the pretreatment of T-cell lymphoma underwent autologous stem cell transplantation
Detailed Description:
T-cell lymphoma patients with the indication of autologous stem cell transplantation will be divided into two groupsthe control group will use BEAM as conditioning regimen and the experiment group will use modified BEAM regimenincluded mitoxantrone liposomethen to compare the efficacy and safety of the two conditioning regimens for patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None